Best in Biotech 29 Oct 2024 GPCR therapies: Eight promising biotechs hacking the cell signaling pathway In this article, we take a look at eight biotechs that have acquired funding in recent years to fortify their GPCR-focused pipelines. October 29, 2024 - 11 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Best in Biotech 22 Oct 2024 Eight nanotechnology companies to watch out for Here are eight nanotechnology companies that are widening the scope in medicine, that you should know about. October 22, 2024 - 10 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 18 Oct 2024 The AI boom in cancer: Game-changer or just hype? Is AI just hype or a game-changer? Delve into AI’s contribution to oncology, from diagnostics to drug discovery and personalized treatment. October 18, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Best in Biotech 17 Oct 2024 Top six European biotech entrepreneurs to know in 2024 (according to VCs) We reached out to VCs to nominate prominent European entrepreneurs in the biotech industry who are committed to bringing potentially life-changing treatments to market. October 17, 2024 - 8 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
In Depth 16 Oct 2024 JAK inhibitors: Are they a good option for treating inflammatory diseases and cancer? Find out more about JAK inhibitors and whether they are a good option for treating inflammatory diseases and cancer. October 16, 2024 - 9 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Podcast 11 Oct 2024Bispecific ADCs: the next generation of cancer treatments To talk about bispecific ADCs, and biotechs in Czechia, our conversation this week is with Radek Špíšek, CEO of SOTIO. October 11, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
Sponsored by Indivumed Therapeutics 8 Oct 2024 How an innovative, data-driven approach is revolutionizing drug discovery for solid tumors Learn how cancer tissue biobanks and insights into solid tumor heterogeneity are transforming drug discovery and paving the way for innovative treatments. October 8, 2024 - 6 minutesmins - By Ute Boronowsky Share WhatsApp Twitter Linkedin Email
Podcast 4 Oct 2024Targeting telomerase to disrupt cancer Listen to our conversation with Vlad Vitoc, CEO of MAIA, on the pioneering approach of telomere targeting October 4, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
News and Trends 27 Sep 2024 Aptadir Therapeutics launches to develop new class of RNA inhibitors against cancer and genetic disorders Italian startup Aptadir Therapeutics has launched with $1.6 million to bring a new class of drugs to the clinic and a technology to be reckoned with. September 27, 2024 - 6 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
Podcast 27 Sep 2024Harnessing the body’s natural targeted protein degradation system to treat diseases Listen to our conversation with Andrew Hirsch, CEO at C4 Therapeutics, a leader in the targeted protein degradation field. September 27, 2024 Share WhatsApp Twitter Linkedin Email Listen Now Apple Music Spotify More
In Depth 26 Sep 2024 The radiopharmaceutical revolution: From diagnosis to treatment, oncology and beyond Delve into the world of radiopharmaceuticals: explore their mechanisms, promising candidates, and the key players driving innovation. September 26, 2024 - 14 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Reports 25 Sep 2024Current trends & innovations in 3D organoids Discover how 3D organoids are already shaping research & drug development today and explore their future potential. September 25, 2024 Share WhatsApp Twitter Linkedin Email